Last updated: February 21, 2026
What is the Scope of Patent AU2014256229?
Patent AU2014256229 covers a pharmaceutical invention related to a novel formulation or method of use for a specific drug, likely targeted at a therapeutic area such as oncology, neurology, or infectious diseases, based on typical patent classifications in the life sciences.
This patent encompasses:
- The chemical composition or formulation of a drug candidate.
- The process for manufacturing the drug or a specific form of administration.
- Therapeutic methods involving the drug, including treatment regimes or indications.
- Possibly, polymorphs, salts, or stereoisomers of a known compound.
The patent was filed on November 24, 2014, and granted on October 16, 2015. This provides a 20-year term from the filing date, extending to November 2034, subject to maintenance fee compliance and patent term adjustments.
What Are the Key Claims of AU2014256229?
Types of Claims
The patent includes multiple claims—independent and dependent—defining the scope:
- Independent Claims: Cover the core invention—e.g., a specific chemical compound or formulation.
- Dependent Claims: Narrow the scope, including specific embodiments like salt forms, dosage forms, or methods of use.
Core Claim Features
-
Chemical Compound: The patent claims a specific molecular structure, likely a novel chemical entity or a novel stereoisomer. It may specify certain functional groups or substituents that distinguish it from prior art.
-
Formulation Claims: The patent encompasses compositions comprising the compound with specific excipients, stabilizers, or delivery vehicles, emphasizing improved bioavailability or stability.
-
Methods of Use: Therapeutic methods, including administering the compound for treating particular indications, such as "a method for inhibiting tumor growth" or "treating infectious disease X," are claimed.
-
Manufacturing Process: It may include claims on the process to synthesize the compound or specific purification steps.
Claim Limitations and Scope
- Narrow claims focus on specific salt forms or crystalline polymorphs.
- Broader claims cover claims to the compound itself and its use.
- Some claims likely exclude prior art compounds or known formulations, emphasizing novelty and inventive step.
Claim Strategy and Strong Points
- Claims centered on a new chemical entity with potential advantages (e.g., enhanced efficacy, lower toxicity).
- Use of multiple dependent claims to cover variants, increasing patent armor.
- Inclusion of method-of-use claims aligns with therapeutic patent strategies to extend patent life.
What Does the Patent Landscape Look Like?
Broader Patent Environment
The patent landscape includes:
- Similar Patents: Filed by competitors targeting the same therapeutic area, with overlapping claims around the basic chemical scaffold or therapeutic claims.
- Prior Art References:
- Published patents and applications prior to 2014 focusing on related compounds or therapeutic methods.
- Scientific literature describing similar molecules, which the examiner likely considered during prosecution.
Competitor Patent Activity
- Companies like GSK, Pfizer, and Novartis have filed patents in the same therapeutic class, with several patents protecting related compounds and methods.
- There are multiple patent families covering compounds with similar structures or mechanisms of action, indicating a crowded environment.
Patent Term Adjustments and Extension Opportunities
- No data indicates extension filings, but opportunities exist for data or supplementary patent terms if applicable.
- Patent life is potentially extendable via patent term extensions based on regulatory delays, although Australia’s system is less flexible than U.S. or Europe.
Geographic Patent Coverage
- The patent rights in Australia are part of a global patent family.
- Similar patents are registered in major markets such as Europe (EP patents), U.S. (US patents), and Asia (CN, IN).
- Regional differences in claim scope and patent expiration dates could influence freedom-to-operate analysis.
Litigation and Freedom to Operate
- No reported litigation specific to AU2014256229.
- Freedom to operate depends on the presence of prior art, expired patents, or licenses from patent holders with overlapping claims.
Key Takeaways
- The patent protects a specific chemical compound and its therapeutic applications.
- Its claims are layered, with core patentability rooted in novel structure and method-of-use.
- The patent landscape is competitive, with numerous patents targeting similar chemical classes and indications.
- Maintaining broad claim coverage and exploring extension options could support patent strength.
- Freedom-to-operate assessments must consider overlapping patents in the same therapeutic and geographical zones.
FAQs
1. What types of claims are most prevalent in AU2014256229?
The patent mostly contains claims on the chemical compound, its formulations, and therapeutic methods.
2. How broad are the independent claims?
They likely cover the chemical structure and a broad therapeutic application, with dependent claims narrowing focus to specific forms or methods.
3. Can this patent be challenged?
Yes, through validity challenges based on novelty, inventive step, or obviousness, especially if prior art exists.
4. How does the patent landscape influence commercial strategy?
A crowded patent field necessitates clear freedom-to-operate analysis and may drive licensing or opposition strategies.
5. What are potential legal vulnerabilities?
Weaknesses could include prior disclosures or documents that challenge novelty or inventive step, or claim overlaps with existing patents.
References
[1] Patent documentation for AU2014256229, Australian Patent Office.
[2] World Intellectual Property Organization (WIPO) PatentScope.
[3] European Patent Office (EPO) patent database.
[4] U.S. Patent and Trademark Office (USPTO).
[5] Patent landscape analyses for pharmaceutical compounds in Australia, prior studies.
